Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Can a rapid measure of self-exposure to drugs of abuse provide dimensional information on depression comorbidity?

Butelman ER, Bacciardi S, Maremmani AGI, Darst-Campbell M, Correa da Rosa J, Kreek MJ.

Am J Addict. 2017 Sep;26(6):632-639. doi: 10.1111/ajad.12578. Epub 2017 Jun 27.

PMID:
28654734
2.

Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.

Kenney SR, Bailey GL, Anderson BJ, Stein MD.

Addict Behav. 2017 Oct;73:124-128. doi: 10.1016/j.addbeh.2017.05.009. Epub 2017 May 9.

PMID:
28505487
3.

Depressive symptoms mediate the relationship between changes in emotion regulation during treatment and abstinence among women with alcohol use disorders.

Holzhauer CG, Gamble SA.

Psychol Addict Behav. 2017 May;31(3):284-294. doi: 10.1037/adb0000274. Epub 2017 Apr 3.

PMID:
28368158
4.

Patterns of marijuana use among psychiatry patients with depression and its impact on recovery.

Bahorik AL, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD.

J Affect Disord. 2017 Apr 15;213:168-171. doi: 10.1016/j.jad.2017.02.016. Epub 2017 Feb 14.

PMID:
28242498
5.

Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression.

Neupane SP.

Front Immunol. 2016 Dec 27;7:655. doi: 10.3389/fimmu.2016.00655. eCollection 2016. Review.

6.

Prevalence and correlates of psychological distress symptoms among patients with substance use disorders in drug rehabilitation centers in urban Nepal: a cross-sectional study.

Gyawali B, Choulagai BP, Paneru DP, Ahmad M, Leppin A, Kallestrup P.

BMC Psychiatry. 2016 Sep 8;16(1):314. doi: 10.1186/s12888-016-1003-6.

7.

The efficacy of behavioural activation treatment for co-occurring depression and substance use disorder (the activate study): a randomized controlled trial.

Ross J, Teesson M, Lejuez C, Mills K, Kaye S, Brady K, Dore G, Prior K, Larkin X, Cassar J, Ewer P, Memedovic S, Kihas I, Masters SL.

BMC Psychiatry. 2016 Jul 8;16:221. doi: 10.1186/s12888-016-0943-1.

8.

Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Russell SE, Puttick DJ, Sawyer AM, Potter DN, Mague S, Carlezon WA Jr, Chartoff EH.

J Neurosci. 2016 May 25;36(21):5748-62. doi: 10.1523/JNEUROSCI.2875-12.2016.

9.

Developing an Experiential Definition of Recovery: Participatory Research With Recovering Substance Abusers From Multiple Pathways.

Borkman TJ, Stunz A, Kaskutas LA.

Subst Use Misuse. 2016 Jul 28;51(9):1116-29. doi: 10.3109/10826084.2016.1160119. Epub 2016 May 9.

10.

Initiation and retention in couples outpatient treatment for parents with drug and alcohol use disorders.

Braitman AL, Kelley ML.

Exp Clin Psychopharmacol. 2016 Jun;24(3):174-84. doi: 10.1037/pha0000072. Epub 2016 Apr 11.

11.

Occipital event-related potentials to addiction-related stimuli in detoxified patients with alcohol dependence, and their association with three-month relapse.

Matheus-Roth C, Schenk I, Wiltfang J, Scherbaum N, Müller BW.

BMC Psychiatry. 2016 Mar 21;16:74. doi: 10.1186/s12888-016-0782-0.

12.

Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Kerridge BT, Saha TD, Chou SP, Zhang H, Jung J, Ruan WJ, Smith SM, Huang B, Hasin DS.

Drug Alcohol Depend. 2015 Nov 1;156:47-56. doi: 10.1016/j.drugalcdep.2015.08.026. Epub 2015 Sep 2.

13.

5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking.

You IJ, Wright SR, Garcia-Garcia AL, Tapper AR, Gardner PD, Koob GF, David Leonardo E, Bohn LM, Wee S.

Neuropsychopharmacology. 2016 Apr;41(5):1210-22. doi: 10.1038/npp.2015.268. Epub 2015 Sep 1.

14.

Assessment and treatment of mood disorders in the context of substance abuse.

Tolliver BK, Anton RF.

Dialogues Clin Neurosci. 2015 Jun;17(2):181-90. Review.

15.
16.

Sociodemographic Factors and Comorbidities Associated with Remission from Alcohol Dependence: Results from a Nationwide General Population Survey in Korea.

Han SY, Cho MJ, Won S, Hong JP, Bae JN, Cho SJ, Park JI, Lee JY, Jeon HJ, Chang SM.

Psychiatry Investig. 2015 Jul;12(3):316-23. doi: 10.4306/pi.2015.12.3.316. Epub 2015 Jul 6.

17.

Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population.

Hasin DS, Shmulewitz D, Stohl M, Greenstein E, Aivadyan C, Morita K, Saha T, Aharonovich E, Jung J, Zhang H, Nunes EV, Grant BF.

Drug Alcohol Depend. 2015 Jul 1;152:246-56. doi: 10.1016/j.drugalcdep.2015.03.027. Epub 2015 Apr 6.

18.

Diffusivity of the uncinate fasciculus in heroin users relates to their levels of anxiety.

Wong NM, Cheung SH, Chan CC, Zeng H, Liu YP, So KF, Lee TM.

Transl Psychiatry. 2015 Apr 28;5:e554. doi: 10.1038/tp.2015.48.

19.

The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample.

Hasin DS, Greenstein E, Aivadyan C, Stohl M, Aharonovich E, Saha T, Goldstein R, Nunes EV, Jung J, Zhang H, Grant BF.

Drug Alcohol Depend. 2015 Mar 1;148:40-6. doi: 10.1016/j.drugalcdep.2014.12.011. Epub 2014 Dec 18.

20.

Self-efficacy and social networks after treatment for alcohol or drug dependence and major depression: disentangling person and time-level effects.

Worley MJ, Trim RS, Tate SR, Roesch SC, Myers MG, Brown SA.

Psychol Addict Behav. 2014 Dec;28(4):1220-9. doi: 10.1037/a0037901. Epub 2014 Oct 27.

Supplemental Content

Support Center